These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Good cell culture practice (GCCP)--an initiative for standardization and quality control of in vitro studies. The establishment of an ECVAM Task Force on GCCP]. Hartung T; Gstraunthaler G; Coecke S; Lewis D; Blanck O; Balls M ALTEX; 2001; 18(1):75-8. PubMed ID: 11248855 [TBL] [Abstract][Full Text] [Related]
3. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. Pamies D; Bal-Price A; Chesné C; Coecke S; Dinnyes A; Eskes C; Grillari R; Gstraunthaler G; Hartung T; Jennings P; Leist M; Martin U; Passier R; Schwamborn JC; Stacey GN; Ellinger-Ziegelbauer H; Daneshian M ALTEX; 2018; 35(3):353-378. PubMed ID: 29697851 [TBL] [Abstract][Full Text] [Related]
4. Good Cell Culture Practice for stem cells and stem-cell-derived models. Pamies D; Bal-Price A; Simeonov A; Tagle D; Allen D; Gerhold D; Yin D; Pistollato F; Inutsuka T; Sullivan K; Stacey G; Salem H; Leist M; Daneshian M; Vemuri MC; McFarland R; Coecke S; Fitzpatrick SC; Lakshmipathy U; Mack A; Wang WB; Yamazaki D; Sekino Y; Kanda Y; Smirnova L; Hartung T ALTEX; 2017; 34(1):95-132. PubMed ID: 27554434 [TBL] [Abstract][Full Text] [Related]
5. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Pamies D; Leist M; Coecke S; Bowe G; Allen DG; Gstraunthaler G; Bal-Price A; Pistollato F; de Vries RBM; Hogberg HT; Hartung T; Stacey G ALTEX; 2022; 39():30-70. PubMed ID: 34882777 [TBL] [Abstract][Full Text] [Related]
6. 21st Century Cell Culture for 21st Century Toxicology. Pamies D; Hartung T Chem Res Toxicol; 2017 Jan; 30(1):43-52. PubMed ID: 28092941 [TBL] [Abstract][Full Text] [Related]
7. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation. De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383 [TBL] [Abstract][Full Text] [Related]
8. Alternatives to animal experimentation in basic research. Gruber FP; Hartung T ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255 [TBL] [Abstract][Full Text] [Related]
9. 4th Annual Predictive Toxicology Summit 2012. Cui Z Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):1061-6. PubMed ID: 23705810 [TBL] [Abstract][Full Text] [Related]
10. ESTIV questionnaire on the acquisition and use of primary human cells and tissue in toxicology. Sladowski D; Combes R; van der Valk J; Nawrot I; Gut G Toxicol In Vitro; 2005 Oct; 19(7):1009-13. PubMed ID: 16150566 [TBL] [Abstract][Full Text] [Related]
11. Stem cell-derived systems in toxicology assessment. Suter-Dick L; Alves PM; Blaauboer BJ; Bremm KD; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M Stem Cells Dev; 2015 Jun; 24(11):1284-96. PubMed ID: 25675366 [TBL] [Abstract][Full Text] [Related]
12. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212 [TBL] [Abstract][Full Text] [Related]
13. Report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Framework for validation and implementation of in vitro toxicity tests. Goldberg AM; Frazier JM; Brusick D; Dickens MS; Flint O; Gettings SD; Hill RN; Lipnick RL; Renskers KJ; Bradlaw JA Xenobiotica; 1993 May; 23(5):563-72. PubMed ID: 8342302 [TBL] [Abstract][Full Text] [Related]
14. Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0) - Draft for stakeholder discussion and call for action. Pamies D; Leist M; Coecke S; Bowe G; Allen D; Gstraunthaler G; Bal-Price A; Pistollato F; DeVries R; Hartung T; Stacey G ALTEX; 2020; 37(3):490-492. PubMed ID: 32686838 [No Abstract] [Full Text] [Related]
15. Toxicology in the 21st century--working our way towards a visionary reality. Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664 [TBL] [Abstract][Full Text] [Related]
16. Do we need a "Chair of alternative methods", and where? Wendel A ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011 [TBL] [Abstract][Full Text] [Related]
17. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions. Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917 [TBL] [Abstract][Full Text] [Related]
18. Ensuring quality of in vitro alternative test methods: issues and answers. Gupta K; Rispin A; Stitzel K; Coecke S; Harbell J Regul Toxicol Pharmacol; 2005 Dec; 43(3):219-24. PubMed ID: 16099570 [TBL] [Abstract][Full Text] [Related]
19. Cell culture systems and in vitro toxicity testing. Technical report no. 4 of the Johns Hopkins Center for Alternatives to Animal Testing (CAAT): technical workshop of June 13-15, 1990. Cytotechnology; 1992; 8(2):129-76. PubMed ID: 1368813 [No Abstract] [Full Text] [Related]